Sept. 25, 2017
Florence, a company advancing clinical research through software, and Verady, a blockchain asset assurance company, have announced a partnership to develop applications that harness blockchain for the advancement of healthcare and clinical research.
Florence manages patient and trial data for thousands of clinical investigators and research sponsors. Verady develops technologies that make asset assurance through blockchain easy and secure, a press release said.
The companies said that as part of the partnership, the Verady application programming interface will provide an easy-to-use, standardized representational state transfer interface to mitigate the complexities of blockchain for Florence's customers.
"Our technology allows healthcare providers and pharmaceutical companies to fingerprint critical data and manage its use in a secure blockchain system," Verady CEO Kell Canty said in the release. "By controlling security and privacy through blockchain, we help Florence to enable new uses of patient data and help research teams deliver new discoveries."
"The Florence-Verady partnership allows research sites and pharmaceutical companies more control over patient data through blockchain," Florence CTO Andres Garcia said. "Patient and clinical trial data managed through the Verady API allows research teams to take advantage of terabytes of patient data while respecting patient rights."
The partnership will develop open source blockchain applications to manage patient and clinical trial data, in conjunction with several pharmaceutical sponsors, the release said.
Source：Read the official page